NCT02740244

Brief Summary

The aim is to evaluate the evaluate the clinical interest and the safety of repetitive transcranial magnetic stimulation (rTMS) delivered as intermittent Theta burst stimulation(iTBS) on severity of depression in patients with treatment-resistant bipolar disorder.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2011

Longer than P75 for not_applicable

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 15, 2016

Completed
Last Updated

August 2, 2018

Status Verified

July 1, 2018

Enrollment Period

1 month

First QC Date

April 6, 2016

Last Update Submit

July 31, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Beck Depression Inventory

    Self-reported clinical scale with 13 items

    2 time point measure, before and after the end of stimulation sessions (changes from baseline BDI scores at 6 weeks)

Study Arms (2)

active iTBS

ACTIVE COMPARATOR

Participants will receive 10 to 30 sessions of active intermittent theta burst stimulation (iTBS) consisting in delivering 2 s train of bursts containing three pulses at 50 Hz repeated each 200 ms every 10 s (iTBS). Each iTBS session contained 990 pulses and lasted 6 min. Stimulation intensity will be set at 80% of the patient's resting motor threshold. iTBS will be applied twice per day, with at least three hours between each session. Ten to 30 sessions will be delivered until patient achieved remission (i.e., 13-item Beck Depression Inventory (BDI13) score \< 10). iTBS will be applied over the left dorsolateral prefrontal cortex (DLPFC) according to the individual's 3D-T1 MRI.

Device: active iTBS

sham iTBS

SHAM COMPARATOR

The same protocol (location, intensity, parameters of stimulation) will be applied using a commercial sham coil.

Device: sham iTBS

Interventions

Transcranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a figure-eight coil (MCF-B65)

Also known as: intermittent Theta Burst stimulation; rTMS stimulator, rTMS
active iTBS
sham iTBSDEVICE

Transcranial magnetic stimulation. MagProX100 (MagVenture, Denmark) with a sham figure-eight coil (MCF-P-B65)

Also known as: sham intermittent Theta Burst stimulation; sham rTMS
sham iTBS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders, DSM-IV criteria
  • Montgomery and Asberg depression scale \> 20

You may not qualify if:

  • other psychiatric features, rapid cycles
  • Benzodiazepines intake
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bipolar Disorder

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • David Szekely, MD

    University Hospital, Grenoble

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2016

First Posted

April 15, 2016

Study Start

January 1, 2011

Primary Completion

February 1, 2011

Study Completion

January 1, 2015

Last Updated

August 2, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share